Munawar Saba, Anderson Corey L, Reilly Louise, Woltz Ryan, Kiani Yusra Sajid, Chiamvimonvat Nipavan, Eckhardt Lee L
Cellular and Molecular Arrhythmia Research Program, Department of Medicine, University of Wisconsin- Madison School of Medicine and Public Health, Madison, USA.
Division of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, University of California, Davis, Davis, CA, USA.
Sci Rep. 2025 Apr 2;15(1):11290. doi: 10.1038/s41598-025-95062-2.
KCNJ2 encodes the inward rectifying potassium channel (Kir2.1) that underlies I which maintains the cardiac resting membrane potential and regulates excitability. Mutations in KCNJ2 have been linked to several clinical phenotypes associated with life-threatening ventricular arrhythmia and sudden death including Andersen-Tawil syndrome (ATS) from loss of function mutations, and Short QT Syndrome 3 from gain of function mutations. Detailed structural-functional relationships to explain the arrhythmia phenotypes are understudied and limit the capacity to provide precision medicine. Here, we combine in-depth and complementary computational molecular modeling techniques with functional analysis from three patients with ATS that harbor KCNJ2 mutations R67Q, R218L, and G300D. Whole-cell patch-clamp experiments revealed loss of function in homomeric mutant channels. Full-length Kir2.1 models were developed for structure-based investigation, and mutations were introduced in both open and closed conformations. Site-directed mutagenesis identified altered interaction profiles contributing to structural perturbations. Molecular dynamics simulations assessed the impact of each mutation on overall channel conformation and stability. Principal component analysis and normal mode analysis revealed mutation-specific structural perturbations. The findings afford atomic mechanistic underpinnings of mutation-specific perturbations. Our multifaceted approach provides first atomic-level insights into the molecular mechanisms underlying ATS, paving the way for structure-guided targeted therapeutic strategies for ATS and related channelopathies.
KCNJ2编码内向整流钾通道(Kir2.1),该通道是维持心脏静息膜电位并调节兴奋性的I电流的基础。KCNJ2中的突变与几种与危及生命的室性心律失常和猝死相关的临床表型有关,包括功能丧失突变导致的安德森-塔维尔综合征(ATS),以及功能获得突变导致的短QT综合征3型。用于解释心律失常表型的详细结构-功能关系研究不足,限制了提供精准医学的能力。在此,我们将深入且互补的计算分子建模技术与来自三名携带KCNJ2突变R67Q、R218L和G300D的ATS患者的功能分析相结合。全细胞膜片钳实验揭示了同源突变通道的功能丧失。开发了全长Kir2.1模型用于基于结构的研究,并在开放和关闭构象中引入突变。定点诱变确定了导致结构扰动的相互作用谱改变。分子动力学模拟评估了每个突变对整体通道构象和稳定性的影响。主成分分析和正常模式分析揭示了突变特异性的结构扰动。这些发现为突变特异性扰动提供了原子层面的机制基础。我们的多方面方法首次提供了关于ATS潜在分子机制的原子水平见解,为针对ATS和相关通道病的结构导向靶向治疗策略铺平了道路。